Immunome Inc
Biotechnology
Healthcare
IMNM
87.01 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
9.86
52 week high
15.97
high
10.74
52 week low
0.00
low
9.85
growth
-29.55 %
previous Close
9.77
P/E ratio
market cap
843 M
div yield
0
usd
Jun 2025
qoq
revenue
4.02 M
37.22 %
net incoming
-43.40 M
-4.22 %
eps
0.00 %
3.85 %
eps surprise
19.59 %
net profit margin
-1080.87 %
342.00 %
operating incoming
-46.48 M
-4.13 %
net change in cash
-113.63 M
-199.44 %
cash on hand
144 M
-44.15 %
cost of revenue
0.00 %
top top